𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)

✍ Scribed by Janet S. Graham; Ruth Plummer; Candice McCoy; Kristin Kowal; Herbert Wiesinger; Katharina Detjen; Hilary Calvert; Bertram Wiedenmann; Jim Cassidy


Book ID
116429697
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
152 KB
Volume
44
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.